Michael Campbell, CPA

Executive Vice President and Chief Financial Officer at ReForm Biologics

Michael Campbell, CPA has over 30 years of experience in the finance and accounting industry. In 1989, they began their career at EY as a Financial and Information Systems Manager. In 1995, they joined Boston Scientific as Vice President of Investor Relations. During their time there, they were also Vice President of Finance, Asia Pacific/Emerging Markets and Vice President and Assistant Corporate Controller. In 2014, they joined Ortho Clinical Diagnostics as Vice President, Corporate Controller and Head of Global Tax, where they were an active member of the IPO Readiness Executive Steering Committee and was directly responsible for several critical workstreams that generated approximately $1.5 billion in gross proceeds as part of the company's initial public offering. In 2022, Michael began working at Comera Life Sciences as Executive Vice President and Chief Financial Officer, and at Monomoy Advisors as CFO Practice - Senior Consultant.

Michael Campbell, CPA graduated from Bentley University in 1989 with a Bachelor of Science in Accountancy. Prior to that, they attended Cardinal Spellman High School.

Links

Previous companies

Monomoy Advisors logo
Boston Scientific logo

Peers

View in org chart

Timeline

  • Executive Vice President and Chief Financial Officer

    June, 2022 - present